You just read:

Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain diseases with up to 94% accuracy

News provided by

Hikma Pharmaceuticals USA Inc.

May 04, 2020, 08:00 ET